Study Evaluating the Efficacy and Safety of AB928-Based

Recruiting

18 years - 99 years

All

Phase 1

200 participants needed

1 Location

Brief description of study

This study will evaluate the efficacy of investigational drug treatments combinations in patients with metastatic colorectal cancer.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: Metastatic Colorectal Cancer
Age: 18 years - 99 years
Gender: All

Male and female participants ≥ 18 years of age, Metastatic colorectal adenocarcinoma

Updated on 04 Aug 2024. Study ID: 849263

Find a site

Your Information has been sent successfully.

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.

Would you like to be notified about other trials? Sign up for Patient Notification Services.

Send a message

Enter your contact details to connect with study team

Primary Contact

First name*

Last name*

Email*

Phone number*

Preferred way of contact

Race

Ethnicity

Are you Healthy Volunteer

Are you comfortable with the informed consent process?

Yes

Other language

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).

Study Evaluating the Efficacy and Safety of AB928-Based Treatment Combinations in Patients with Metastatic Colorectal Cancer

Brief description of study

Eligibility of study

Find a site

Interested in the study